448 related articles for article (PubMed ID: 16407300)
1. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
Riuzzi F; Sorci G; Donato R
J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
[TBL] [Abstract][Full Text] [Related]
2. RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth.
Riuzzi F; Sorci G; Donato R
Am J Pathol; 2007 Sep; 171(3):947-61. PubMed ID: 17640970
[TBL] [Abstract][Full Text] [Related]
3. Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding.
Sorci G; Riuzzi F; Arcuri C; Giambanco I; Donato R
Mol Cell Biol; 2004 Jun; 24(11):4880-94. PubMed ID: 15143181
[TBL] [Abstract][Full Text] [Related]
4. Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation.
Huttunen HJ; Kuja-Panula J; Rauvala H
J Biol Chem; 2002 Oct; 277(41):38635-46. PubMed ID: 12167613
[TBL] [Abstract][Full Text] [Related]
5. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
Kuniyasu H; Chihara Y; Kondo H
Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
[TBL] [Abstract][Full Text] [Related]
6. S100B engages RAGE or bFGF/FGFR1 in myoblasts depending on its own concentration and myoblast density. Implications for muscle regeneration.
Riuzzi F; Sorci G; Beccafico S; Donato R
PLoS One; 2012; 7(1):e28700. PubMed ID: 22276098
[TBL] [Abstract][Full Text] [Related]
7. S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK.
Riuzzi F; Sorci G; Donato R
J Cell Physiol; 2006 May; 207(2):461-70. PubMed ID: 16419039
[TBL] [Abstract][Full Text] [Related]
8. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site.
Ishihara K; Tsutsumi K; Kawane S; Nakajima M; Kasaoka T
FEBS Lett; 2003 Aug; 550(1-3):107-13. PubMed ID: 12935895
[TBL] [Abstract][Full Text] [Related]
9. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.
Taguchi A; Blood DC; del Toro G; Canet A; Lee DC; Qu W; Tanji N; Lu Y; Lalla E; Fu C; Hofmann MA; Kislinger T; Ingram M; Lu A; Tanaka H; Hori O; Ogawa S; Stern DM; Schmidt AM
Nature; 2000 May; 405(6784):354-60. PubMed ID: 10830965
[TBL] [Abstract][Full Text] [Related]
10. Receptor for advanced glycation end products plays a more important role in cellular survival than in neurite outgrowth during retinoic acid-induced differentiation of neuroblastoma cells.
Sajithlal G; Huttunen H; Rauvala H; Munch G
J Biol Chem; 2002 Mar; 277(9):6888-97. PubMed ID: 11739380
[TBL] [Abstract][Full Text] [Related]
11. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.
Huttunen HJ; Kuja-Panula J; Sorci G; Agneletti AL; Donato R; Rauvala H
J Biol Chem; 2000 Dec; 275(51):40096-105. PubMed ID: 11007787
[TBL] [Abstract][Full Text] [Related]
12. Regulation of monocyte migration by amphoterin (HMGB1).
Rouhiainen A; Kuja-Panula J; Wilkman E; Pakkanen J; Stenfors J; Tuominen RK; Lepäntalo M; Carpén O; Parkkinen J; Rauvala H
Blood; 2004 Aug; 104(4):1174-82. PubMed ID: 15130941
[TBL] [Abstract][Full Text] [Related]
13. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L
Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296
[TBL] [Abstract][Full Text] [Related]
14. S100B causes apoptosis in a myoblast cell line in a RAGE-independent manner.
Sorci G; Riuzzi F; Agneletti AL; Marchetti C; Donato R
J Cell Physiol; 2004 May; 199(2):274-83. PubMed ID: 15040010
[TBL] [Abstract][Full Text] [Related]
15. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways.
Huttunen HJ; Fages C; Rauvala H
J Biol Chem; 1999 Jul; 274(28):19919-24. PubMed ID: 10391939
[TBL] [Abstract][Full Text] [Related]
16. Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells.
Takeuchi A; Yamamoto Y; Munesue S; Harashima A; Watanabe T; Yonekura H; Yamamoto H; Tsuchiya H
Cancer Sci; 2013 Jun; 104(6):740-9. PubMed ID: 23421467
[TBL] [Abstract][Full Text] [Related]
17. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.
Hori O; Brett J; Slattery T; Cao R; Zhang J; Chen JX; Nagashima M; Lundh ER; Vijay S; Nitecki D
J Biol Chem; 1995 Oct; 270(43):25752-61. PubMed ID: 7592757
[TBL] [Abstract][Full Text] [Related]
18. Heparan sulfate is essential for high mobility group protein 1 (HMGB1) signaling by the receptor for advanced glycation end products (RAGE).
Xu D; Young J; Song D; Esko JD
J Biol Chem; 2011 Dec; 286(48):41736-41744. PubMed ID: 21990362
[TBL] [Abstract][Full Text] [Related]
19. HMGB1-RAGE regulates muscle satellite cell homeostasis through p38-MAPK- and myogenin-dependent repression of Pax7 transcription.
Riuzzi F; Sorci G; Sagheddu R; Donato R
J Cell Sci; 2012 Mar; 125(Pt 6):1440-54. PubMed ID: 22328527
[TBL] [Abstract][Full Text] [Related]
20. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis.
Huttunen HJ; Fages C; Kuja-Panula J; Ridley AJ; Rauvala H
Cancer Res; 2002 Aug; 62(16):4805-11. PubMed ID: 12183440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
